Zobrazeno 81 - 90
of 6 275
pro vyhledávání: ''
Autor:
Rafael Rodríguez-Lecoq, Ricard Ferrer, Eduard Argudo, Juan Carlos Ruiz-Rodríguez, Jordi Riera
Publikováno v:
Lancet (London, England). 395(10236)
Autor:
Jingli Wang, Yuan Wei, Yang Han, Ting Yu, Yang Qiu, Jie-Ming Qu, Min Zhou, Nanshan Chen, Xuan Dong, Jia'an Xia, Li Zhang, Ying Liu, Xinxin Zhang, Fengyun Gong
Publikováno v:
The Lancet
In December, 2019, a pneumonia associated with the 2019 novel coronavirus (2019-nCoV) emerged in Wuhan, China. We aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia.In this retrospective, single-centre st
Autor:
John D. Chester, Anthony Blacker, Mark Johnson, Thomas Powles, David Dolling, Satinder Jagdev, Andrew Winterbottom, Alison Birtle, Chris Harris, Paul Anthony Elliott, John Wagstaff, Richard T. Bryan, Robert Jones, Rebecca Lewis, Emma Hall, Francis X. Keeley, Caroline Wilson, Rachel Todd, Benjamin Jenkins, Ann French, James W.F. Catto, Jenny L Donovan, Prabir Chakraborti, Roger Kockelbergh
Publikováno v:
Birtle, A, Johnson, M, Donovan, J L & al., E 2020, ' Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial) : a phase 3, open-label, randomised controlled trial ', Lancet, vol. 395, no. 10232, pp. 1268-1277 . https://doi.org/10.1016/S0140-6736(20)30415-3
Lancet (London, England)
Lancet (London, England)
Background:\ud Urothelial carcinomas of the upper urinary tract (UTUCs) are rare, with poorer stage-for-stage prognosis than urothelial carcinomas of the urinary bladder. No international consensus exists on the benefit of adjuvant chemotherapy for p
Autor:
Laura Salm-Reifferscheidt
Publikováno v:
Lancet (London, England). 395(10217)
Autor:
Deodhar, Atul, Helliwell, Philip S, Boehncke, Wolf-Henning, Kollmeier, Alexa P, Hsia, Elizabeth C, Subramanian, Ramanand A, Xu, Xie L, Sheng, Shihong, Agarwal, Prasheen, Zhou, Bei, Zhuang, Yanli, Ritchlin, Christopher T, DISCOVER-1 Study Group
Publikováno v:
Lancet, Vol. 395, No 10230 (2020) pp. 1115-1125
Many patients with psoriatic arthritis have an inadequate response to tumor necrosis factor (TNF) inhibitors. Guselkumab, a specific inhibitor of interleukin-23 (IL-23) via IL-23 p19 subunit binding, significantly improved psoriatic arthritis signs a
Autor:
Stefan J. Marciniak, Steven Walker, Edward McKeown, Alex West, James A Cameron, I Fairbairn, Corran Roberts, Robert J. Hallifax, John P. Corcoran, Amrithraj Bhatta, Raja Reddy, Kevin G. Blyth, Nick A Maskell, Andrew R. Leitch, Matthew Knight, Najib M. Rahman, Christy Peter, John E Harvey, Robert F. Miller, N. Maddekar, Magda Laskawiec-Szkonter, Parthipan Sivakumar, Marie-Clare Harris, Stephen Gerry, Andrew E. Stanton, Asim Ijaz
Publikováno v:
Hallifax, R J, Walker, S, Maskell, N, Rahman, N M & al., E 2020, ' Ambulatory management of primary spontaneous pneumothorax : an open-label, randomised controlled trial ', Lancet, vol. 396, no. 10243, pp. 39-49 . https://doi.org/10.1016/S0140-6736(20)31043-6
Background Primary spontaneous pneumothorax occurs in otherwise healthy young patients. Optimal management is not defined and often results in prolonged hospitalisation. Data on efficacy of ambulatory options are poor. We aimed to describe the durati
Autor:
Ruyan Pang, Haidong Wang, Carine Ronsmans, Yunting Zhang, Linhong Wang, George C Patton, Robert J. Norman, Xiaohong Li, Li Song, Fan Jiang, Xu Qian, Duan Ma, Jie Qiao, Jun Zhang, Yuanyuan Wang, Yan Guo, Peter C.K. Leung, Jun Zhu, Joy E Lawn, Jie Qiu, Wei Fu, Li Liu, J Wu, Jun Ma, Robert E. Black, Hsun Ming Chang, Yi Song, Zhaofang Zhu, Meng Mao, Therese Hesketh, Jing Ma
Publikováno v:
Lancet (London, England). 397(10293)
Publikováno v:
Lancet (London, England). 395(10237)
Autor:
Daniella Lent-Schochet, Glenn Yiu
Publikováno v:
Lancet (London, England). 395(10238)
Publikováno v:
Community-Acquired Pneumonia
Community-acquired pneumonia is not usually considered a high-priority problem by the public, although it is responsible for substantial mortality, with a third of patients dying within 1 year after being discharged from hospital for pneumoniae. Alth